Novartis AG
HEPATITIS B ANTIBODIES
Last updated:
Abstract:
The present invention relates to anti-HBsAg antibodies, antibody fragments, and their uses for the prevention and treatment of hepatitis B virus infection and associated diseases.
Status:
Application
Type:
Utility
Filling date:
30 May 2019
Issue date:
22 Jul 2021